Canada markets close in 25 minutes

Vaccinex, Inc. (VCNX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.90+0.44 (+6.81%)
As of 03:22PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
50
570
275
900
50
-
Cost of Revenue
-
-
-
0
2
199
Gross Profit
-
-
-
900
48
324
Operating Expenses
Research Development
14,192
16,574
13,979
17,160
21,549
-
Selling General and Administrative
6,163
6,881
6,202
6,230
7,405
-
Total Operating Expenses
20,355
23,455
20,181
23,390
28,379
-
Operating Income or Loss
-20,305
-22,885
-19,906
-22,490
-28,331
-
Interest Expense
-14
1
2
809
489
-
Total Other Income/Expenses Net
923
2,635
93
919
-31
-
Income Before Tax
-19,368
-20,251
-19,815
-22,380
-28,851
-
Income Tax Expense
0
0
0
0
0
-
Income from Continuing Operations
-19,368
-20,251
-19,815
-22,380
-28,851
-
Net Income
-19,368
-20,251
-19,815
-22,380
-28,851
-
Net Income available to common shareholders
-19,368
-20,251
-19,815
-22,380
-28,851
-
Basic EPS
-83.86
-43.68
-98.05
-163.80
-323.40
-
Diluted EPS
-83.86
-43.68
-98.05
-163.80
-323.40
-
Basic Average Shares
266.151
463.652
202.082
137.377
89.46
-
Diluted Average Shares
266.151
463.652
202.082
137.377
89.46
-